Impact of pericoronary adipose tissue attenuation on recurrence after radiofrequency catheter ablation for atrial fibrillation
Clinical Cardiology · 2023-10 · 46 (10) · 1244-1252
DOI: 10.1002/clc.24081 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Cardiology, online erschienen am 12.07.2023. Verfasst von Zhe Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, China-Japan Friendship Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. Hauptthemen laut MEDLINE: Atrial Fibrillation, Catheter Ablation. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: None.
Abstract (Originalsprache)
Background
Inflammation plays a vital role in the occurrence and progression of atrial fibrillation (AF). The association between pericoronary adipose tissue attenuation (PCATA) and AF recurrence following ablation has not been fully clarified. Hypothesis We aimed to evaluate the association between PCATA and AF recurrence after radiofrequency catheter ablation (RFCA).
Methods
Patients who underwent the first RFCA for AF and performed coronary computed tomography angiography before ablation between 2018 and 2021 were enrolled. The predictive values of PCATA for AF recurrence after ablation were investigated. The area under curve (AUC), relative integrated discrimination improvement (IDI), and categorical free net reclassification improvement (NRI) were used to assess the discrimination ability of different models for AF recurrence.
Results
During 1‐year follow‐up, 34.1% patients experienced AF recurrence. The multivariable analysis model revealed that PCATA of the right coronary artery (RCA) was an independent risk factor for AF recurrence. Patients with a high level of RCA‐PCATA had a high risk of recurrence, after adjusting for other risk factors by restricted cubic splines. The performance in predicting AF recurrence was significantly improved by adding the marker of RCA‐PCATA to the clinical model (AUC: 0.724 vs. 0.686, p = .024), with a relative IDI of 0.043 ( p = .006) and continuous NRI of 0.521 ( p < .001).
Conclusions
PCATA of RCA was independently associated with AF recurrence after ablation. PCATA may be helpful for risk classification for AF ablation patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, China-Japan Friendship Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
- Department of Cardiology, Beijing Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
- Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
- Department of Radiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
- Department of Cardiology, Anzhen Hospital Affiliated to Capital Medical University, Beijing, China.
- Department of Cardiology, China-Japan Friendship Hospital, Beijing, China.
Förderung
- None
Zitieren
APA
Wang, Z., Wang, Y. J., Chen, J. W., Ren, L. C., Guo, H. H., Chen, X. J., Dong, J. Z., Chen, Y. W., & Sun, Y. H. (2023). Impact of pericoronary adipose tissue attenuation on recurrence after radiofrequency catheter ablation for atrial fibrillation. Clinical Cardiology, 46(10), 1244-1252. https://doi.org/10.1002/clc.24081
Vancouver
Wang Z, Wang YJ, Chen JW, Ren LC, Guo HH, Chen XJ, et al. Impact of pericoronary adipose tissue attenuation on recurrence after radiofrequency catheter ablation for atrial fibrillation. Clinical Cardiology. 2023;46(10):1244-1252. doi:10.1002/clc.24081
BibTeX
@article{Wang2023,
author = {Wang, Zhe and Wang, Yi-Jia and Chen, Jia-Wei and Ren, Li-Chen and Guo, He-He and Chen, Xiao-Jie and Dong, Jian-Zeng and Chen, Ying-Wei and Sun, Yi-Hong},
title = {Impact of pericoronary adipose tissue attenuation on recurrence after radiofrequency catheter ablation for atrial fibrillation},
journal = {Clinical Cardiology},
year = {2023},
volume = {46},
number = {10},
pages = {1244--1252},
doi = {10.1002/clc.24081}
}
EUVIMED